Indications for chimerism analysis on sorted cell populations after allogeneic hematopoietic stem cell transplantation (SFGM-TC)
Abstract
Chimerism monitoring following allogeneic hematopoietic stem cell transplantation is a key component of post-transplant surveillance. While whole blood chimerism analysis remains the standard approach, lineage-specific chimerism assessment on sorted cell populations has become increasingly common over recent years. However, its actual clinical benefit remains controversial. As part of this SFGM-TC harmonization workshop, a survey of current practices was conducted among French-speaking transplant centers and complemented by a critical review of the literature. The specific objective was to evaluate the added value of lineage-specific chimerism compared with whole blood chimerism. Therefore, the analysis focused on studies directly comparing these two approaches. Indeed, many published studies have investigated chimerism in specific cell populations without direct comparison with whole blood chimerism, making it difficult to assess the true benefit of cell sorting. The available data highlight the widespread use of lineage-specific chimerism monitoring in French-speaking centers, but also reveal substantial heterogeneity in practices, analytical methods, and clinical indications. Although some evidence suggests a potential role for selected cell subsets in specific clinical settings, the limited number of comparative studies and the lack of standardized decision thresholds preclude the establishment of robust consensus recommendations. At present, only targeted use of lineage-specific chimerism can be recommended, whereas whole blood chimerism remains the reference approach. Prospective comparative studies are needed to better define the role of lineage-specific chimerism monitoring in post-transplant follow-up.
Related
- Complete Donor T Cell Chimerism Predicts Lower Relapse Incidence after Standard Double Umbilical Cord Blood Reduced-Intensity Conditioning Regimen Allogeneic Transplantation in Adults
- Longitudinal plasma proteome profiling after allogeneic hematopoietic stem cell transplantation: heterogeneous development and associations with acute GvHD
- Case Report: Fulminant aggressive NK-cell leukemia with hemophagocytic lymphohistiocytosis and multiple organ dysfunction successfully bridged to allogeneic hematopoietic stem cell transplantation
- Allogeneic hematopoietic cell transplantation with reduced-toxicity conditioning for X-linked hyper-IgM syndrome
- T-cell polyfunctionality reconstitution after modified anti-thymocyte globulin plus post-transplant cyclophosphamide in allogeneic hematopoietic stem cell transplantation
BibTeX
@article{jorgecordeiro2026indications,
title = {{Indications for chimerism analysis on sorted cell populations after allogeneic hematopoietic stem cell transplantation (SFGM-TC)}},
author = {Debora Jorge-Cordeiro and Marine Cargou and Roberto Crocchiolo and Jean El-Cheikh and Romain Ferru-Clement and Matthieu Filloux and Claire Geurten and Nicolas Guillaume and Ambroise Marcais and Philippe Moskovtchenko and Thibault Pajot and Flore Sicre de Fontbrune and Mégane Tanguay and Laurie Toullec and Juliette Villemonteix and Aliénor Xhaard and Léonardo Magro and Pascal Pedini},
journal = {Bulletin du Cancer},
year = {2026},
month = oct,
doi = {10.1016/j.bulcan.2026.08.004},
url = {https://u-picardie.hal.science/hal-05777963v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - Indications for chimerism analysis on sorted cell populations after allogeneic hematopoietic stem cell transplantation (SFGM-TC)
AU - Debora Jorge-Cordeiro
AU - Marine Cargou
AU - Roberto Crocchiolo
AU - Jean El-Cheikh
AU - Romain Ferru-Clement
AU - Matthieu Filloux
AU - Claire Geurten
AU - Nicolas Guillaume
AU - Ambroise Marcais
AU - Philippe Moskovtchenko
AU - Thibault Pajot
AU - Flore Sicre de Fontbrune
AU - Mégane Tanguay
AU - Laurie Toullec
AU - Juliette Villemonteix
AU - Aliénor Xhaard
AU - Léonardo Magro
AU - Pascal Pedini
PY - 2026
DA - 2026/10/05
JO - Bulletin du Cancer
DO - 10.1016/j.bulcan.2026.08.004
UR - https://u-picardie.hal.science/hal-05777963v1
AB - Chimerism monitoring following allogeneic hematopoietic stem cell transplantation is a key component of post-transplant surveillance. While whole blood chimerism analysis remains the standard approach, lineage-specific chimerism assessment on sorted cell populations has become increasingly common over recent years. However, its actual clinical benefit remains controversial. As part of this SFGM-TC harmonization workshop, a survey of current practices was conducted among French-speaking transplant centers and complemented by a critical review of the literature. The specific objective was to evaluate the added value of lineage-specific chimerism compared with whole blood chimerism. Therefore, the analysis focused on studies directly comparing these two approaches. Indeed, many published studies have investigated chimerism in specific cell populations without direct comparison with whole blood chimerism, making it difficult to assess the true benefit of cell sorting. The available data highlight the widespread use of lineage-specific chimerism monitoring in French-speaking centers, but also reveal substantial heterogeneity in practices, analytical methods, and clinical indications. Although some evidence suggests a potential role for selected cell subsets in specific clinical settings, the limited number of comparative studies and the lack of standardized decision thresholds preclude the establishment of robust consensus recommendations. At present, only targeted use of lineage-specific chimerism can be recommended, whereas whole blood chimerism remains the reference approach. Prospective comparative studies are needed to better define the role of lineage-specific chimerism monitoring in post-transplant follow-up.
SN - 0007-4551
SN - 1769-6917
ER -